Viewing Study NCT05036005


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2025-12-26 @ 2:09 AM
Study NCT ID: NCT05036005
Status: UNKNOWN
Last Update Posted: 2023-04-18
First Post: 2021-08-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)
Sponsor: Institut fuer Frauengesundheit
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module